摘要
背景:多形性胶质母细胞瘤是最常见、最致命的脑恶性肿瘤。最近的证据表明,肿瘤内存在干细胞,具有较高的自我更新能力、对化疗的抵抗力和侵袭/迁移潜能,这与GBM预后不良有关。GSC侵袭性似乎与肿瘤发生和转移的一个重要过程有关,即上皮间充质转移(EMT),EMT负责GSCs的多种生化改变和更多间充质表型的获取,从而增强GSC的迁移、侵袭性和抗凋亡能力。目的:由于嘌呤与自身受体相互作用,在GBM和衍生细胞中具有抗肿瘤作用,因此,我们试图研究这些化合物对EMT相关基因/激活剂和/或信号通路上的肿瘤细胞迁移/侵袭的抑制作用。方法:查阅相关文献中与目的相关的文章。结果:研究嘌呤对GSCs EMT信号通路/标记物活性的研究尚不多见,而文献较多。结论:考虑到EMT在GBM侵袭性中的意义和嘌呤在此过程中的潜在参与,我们认为这方面的进一步研究为控制GBM侵袭/复发开辟了一条新的治疗途径。
关键词: 多形性胶质母细胞瘤,胶质母细胞瘤衍生干细胞,上皮间充质转换(EMT),EMT标记物,腺嘌呤基嘌呤,嘌呤受体。
图形摘要
Current Drug Targets
Title:A New Investigational Perspective for Purines Against Glioblastoma Invasiveness
Volume: 19 Issue: 16
关键词: 多形性胶质母细胞瘤,胶质母细胞瘤衍生干细胞,上皮间充质转换(EMT),EMT标记物,腺嘌呤基嘌呤,嘌呤受体。
摘要: Background: Glioblastoma Multiforme (GBM) is the most common and lethal brain malignancy. Recent evidence suggests that the presence of stem-like cells (GSCs) inside the tumor with high self-renewal, resistance to chemotherapy and invasiveness/migration potential is associated with poor GBM prognosis. GSC aggressiveness seems to be linked to an important process involved in tumorigenesis and cancer metastasis called Epithelial-to-Mesenchymal Transition (EMT), which is responsible for several biochemical changes and the acquisition of a more mesenchymal phenotype by GSCs, that enhance their migration, invasiveness and resistance to apoptosis.
Objective: Since previous reports demonstrated that purines, interacting with their own receptors, exerted anti-tumor effects in GBM and derived cells, we tried to investigate the ability of these compounds to reduce tumor cell migration/invasion acting on EMT-associated genes/activators and/or signal pathways.
Methods: Search in the literature of relevant articles related to the objective.
Results: Papers examining the activity of purines on EMT signaling pathways/markers in GSCs are still few whereas literature is more abundant as for other kinds of tumors.
Conclusion: Considering the significance of EMT in GBM aggressiveness and the promising involvement of purines in this process, we think that further research in this regard may open the way towards a new therapeutic approach for the control of GBM invasiveness/recurrence.
Export Options
About this article
Cite this article as:
A New Investigational Perspective for Purines Against Glioblastoma Invasiveness, Current Drug Targets 2018; 19 (16) . https://dx.doi.org/10.2174/1389450119666180226123819
DOI https://dx.doi.org/10.2174/1389450119666180226123819 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Breast Cancer: A Review of Risk Factors and New Insights into Treatment
Current Cancer Therapy Reviews Pharmacology of Sigma (σ) Receptor Ligands from a Behavioral Perspective
Current Pharmaceutical Design Use of Human Umbilical Cord Blood (HUCB) Cells to Repair the Damaged Brain
Current Neurovascular Research Tacrine-based Multifunctional Agents in Alzheimer's Disease: An Old Story in Continuous Development§
Current Medicinal Chemistry Potential Usage of ING Family Members in Cancer Diagnostics and Molecular Therapy
Current Drug Targets Natural Product Inhibitors of the Ubiquitin-Proteasome Pathway
Current Drug Targets Role of Metal Ions in the Aβ Oligomerization in Alzheimers Disease and in Other Neurological Disorders
Current Alzheimer Research Molecular Targeted Approaches to Cancer Therapy and Prevention Using Chalcones
Current Cancer Drug Targets Malaria and artemisinin derivatives: an updated review
Mini-Reviews in Medicinal Chemistry The Molecular and Pharmacological Mechanisms of HIV-Related Neuropathic Pain
Current Neuropharmacology Classical Neurotransmitters and Neuropeptides Involved in Parkinson's Disease: Focus on Anti-Parkinsonian Drugs
Current Drug Therapy Antisense Oligodeoxynucleotide Therapy for Prostate Cancer Targeting Antiapoptotic Genes Involved in the Mechanism Mediating Progression to Androgen Independence
Current Signal Transduction Therapy Review of the Third Domain Receptor Binding Fragment of Alphafetoprotein (AFP): Plausible Binding of AFP to Lysophospholipid Receptor Targets
Current Drug Targets Effect of Genetic Polymorphisms (SNPs) in CHRNA7 Gene on Response to Acetylcholinesterase Inhibitors (AChEI) in Patients with Alzheimer’s Disease
Current Drug Targets Survivin Modulators: An Updated Patent Review (2011 - 2015)
Recent Patents on Anti-Cancer Drug Discovery Regulation of MET Receptor Signaling by SOCS1 and its Implications for Hepatocellular Carcinoma
Current Pharmaceutical Design Tumor Stroma Manipulation By MSC
Current Drug Targets Vascular Endothelial Growth Factor as an Anti-Angiogenic Target for Cancer Therapy
Current Drug Targets Potentiation of Anti-Cancer Treatment by Modulators of Energy Metabolism
Current Pharmaceutical Biotechnology Antipsychotics as Psychosis Drugs and Neuroprotective Promoters Evaluated by Chemical QSAR - in silico and in vivo Studies
Letters in Drug Design & Discovery